Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Some drugs for inflammation may cause psoriasis-like hair loss.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

LL-37 helps stem cells grow and move, aiding tissue regeneration and hair growth.

miR-203a-3p helps hair follicle stem cells become specialized by targeting Smad1.

Blocking TRPV3 may help treat itch in dry skin conditions.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Calancardin B may help reduce inflammation in immune cells.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Recombinant thymosin β4 promotes blood vessel growth and reduces muscle damage.

Leonuri Herba alkaloids may help treat hormone-induced enlarged prostate in rats.

Hinokitiol may help treat hair loss by reducing inflammation and promoting hair growth.

Tralokinumab successfully treated alopecia areata in a patient with atopic dermatitis.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

Ion-paired risedronate significantly increases skin penetration without irritation compared to risedronate alone.

A 532 nm laser at 15 J/cm2 speeds up tendon healing by increasing tendon stem cell growth and tendon-related gene activity.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

Ritlecitinib is effective and safe for long-term treatment of alopecia areata.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

Tislelizumab can cause cutaneous lupus erythematosus.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

A new, efficient method was developed to synthesize a specific compound and its derivatives.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Intralesional triamcinolone acetonide can effectively limit the progression of GLPLS.